Seres Therapeutics Inc
NASDAQ:MCRB

Watchlist Manager
Seres Therapeutics Inc Logo
Seres Therapeutics Inc
NASDAQ:MCRB
Watchlist
Price: 0.5902 USD -11.1% Market Closed
Market Cap: 89.9m USD
Have any thoughts about
Seres Therapeutics Inc?
Write Note

Wall Street
Price Targets

MCRB Price Targets Summary
Seres Therapeutics Inc

Wall Street analysts forecast MCRB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MCRB is 3.9719 USD with a low forecast of 1.01 USD and a high forecast of 10.5 USD.

Lowest
Price Target
1.01 USD
71% Upside
Average
Price Target
3.9719 USD
573% Upside
Highest
Price Target
10.5 USD
1 679% Upside

MCRB Last Price Targets
Seres Therapeutics Inc

The latest public price target was made on Jun 7, 2024 by Keay Nakae from Chardan Capital , who expects MCRB stock to rise by 112% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Keay Nakae
Chardan Capital
1.25 USD
Upside 112%
5 months ago
Jun 7, 2024
Seres Therapeutics price target lowered to $1.25 from $6 at Chardan
TheFly
Keay Nakae
Chardan Capital
Price Target 1.25 USD
Upside/Downside 112%
View Source
Seres Therapeutics Inc Competitors:
Price Targets
MAB
Mabion SA
37% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
119% Upside
BPMC
Blueprint Medicines Corp
34% Upside
688235
Beigene Ltd
14% Upside
002007
Hualan Biological Engineering Inc
30% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
28% Upside
VXRT
Vaxart Inc
590% Upside
ARTV
Artiva Biotherapeutics Inc
85% Upside

Revenue
Forecast

Revenue Estimate
Seres Therapeutics Inc

The compound annual growth rate of Seres Therapeutics Inc's revenue for the next 3 years is -41%.

N/A
Past Growth
-41%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Seres Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Seres Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MCRB's stock price target?
Price Target
3.9719 USD

According to Wall Street analysts, the average 1-year price target for MCRB is 3.9719 USD with a low forecast of 1.01 USD and a high forecast of 10.5 USD.

What is Seres Therapeutics Inc's Revenue forecast?
Projected CAGR
-41%

The compound annual growth rate of Seres Therapeutics Inc's revenue for the next 3 years is -41%.

Back to Top